Related Experiment Video

Updated: Jul 3, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

RASSF1A interacts with and activates the mitotic kinase Aurora-A

L Liu1, C Guo, R Dammann

  • 1Division of Biology, Beckman Research Institute, City of Hope Cancer Center, Duarte, CA 91010, USA.

Oncogene
|July 22, 2008
PubMed

Insights

The RAS association domain family 1A (RASSF1A) gene, a tumor suppressor, regulates cell division by interacting with Aurora-A kinase. RASSF1A influences Aurora-A activation and microtubule stability, impacting centrosome separation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • The RAS association domain family 1A (RASSF1A) gene, located at chromosome 3p21.3, is frequently inactivated in human cancers via promoter methylation.
  • Rassf1a-deficient mice exhibit increased susceptibility to both spontaneous and carcinogen-induced tumors, supporting its role as a tumor suppressor.
  • The precise mechanisms by which RASSF1A exerts its tumor-suppressive functions remain incompletely understood.

Purpose of the Study:

  • To elucidate the role of RASSF1A in tumor suppression pathways.
  • To investigate the interaction between RASSF1A and the mitotic kinase Aurora-A.
  • To determine how RASSF1A influences Aurora-A activation and centrosome separation.

Main Methods:

  • Overexpression and siRNA-mediated knockdown of RASSF1A in cellular models.
  • Analysis of RASSF1A interaction with Aurora-A using co-immunoprecipitation.
  • In vitro kinase assays to assess Aurora-A activation and RASSF1A phosphorylation.
  • Assessment of centrosome separation and microtubule stability.

Main Results:

  • Overexpression of RASSF1A inhibits centrosome separation and leads to microtubule hyperstabilization.
  • RASSF1A interacts with Aurora-A, a key regulator of mitosis.
  • RASSF1A modulates Aurora-A activation; knockdown reduces its activity, while overexpression enhances it.
  • RASSF1A acts as a substrate for Aurora-A in vitro, suggesting a potential scaffolding role in Aurora-A activation.

Conclusions:

  • RASSF1A plays a critical role in regulating mitosis, specifically by influencing Aurora-A activation and centrosome separation.
  • The interaction between RASSF1A and Aurora-A, along with RASSF1A's effect on microtubule dynamics, highlights a novel tumor suppression mechanism.
  • RASSF1A may function as a scaffold protein, facilitating the interaction between Aurora-A and its activators, thereby controlling cell division and preventing tumorigenesis.

More Related Videos

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...